Previous studies have stated that elevated MDSC levels were associated with reduced overall survival in patients with pancreatic cancer [97], and IL-6 produced by PSCs in TME could activate MDSC via JAK/STAT3 (Janus kinase/signal transducer and activator of transcription 3) signaling [98]. Here, IL6 is linked to familial pancreatic carcinoma.